Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olof Strandberg

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Brain : a Journal of Neurology|April 21, 2023
Age-related and amyloid-beta-independent tau deposition and its downstream effectsAnika Wuestefeld, Alexa Pichet Binette, David Berron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical dataLinda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2019
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's diseaseRik Ossenkoppele, Chul Hyoung Lyoo, Carole H Sudre, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
JAMA Neurology|June 10, 2024
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive ImpairmentColin Groot, Ruben Smith, Lyduine E Collij, et al.
JAMA|October 17, 2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersRik Ossenkoppele, Gil D Rabinovici, Ruben Smith, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
Nature Medicine|December 1, 2022
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoringNicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Brain : a Journal of Neurology|April 21, 2023
Age-related and amyloid-beta-independent tau deposition and its downstream effectsAnika Wuestefeld, Alexa Pichet Binette, David Berron, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical dataLinda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 2, 2019
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's diseaseRik Ossenkoppele, Chul Hyoung Lyoo, Carole H Sudre, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Generating synthetic tau-PET scans in Alzheimer's disease from MRI, blood biomarkers and demographics with deep learningLinda Karlsson, Olof Strandberg, Ruben Smith, et al.
JAMA Neurology|June 10, 2024
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive ImpairmentColin Groot, Ruben Smith, Lyduine E Collij, et al.
JAMA|October 17, 2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersRik Ossenkoppele, Gil D Rabinovici, Ruben Smith, et al.
JAMA|July 30, 2020
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersSebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, et al.
Nature Medicine|December 1, 2022
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoringNicholas J Ashton, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Nature Medicine|July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's diseaseKanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Pageof 11